[Combination therapy with ofloxacin and chloramphenicol against typhoid fever].
Recently we experienced two male typhoid patients who required additional treatment with CP sodium succinate (CP succinate) to OFLX therapy. Although both of the cases were administered 900 mg/day of OFLX orally for three and four days, respectively, the clinical efficacies were not sufficient. We added 2.0 g/day of CP succinate intravenously for six days, although a lasting high fever returned to normal level in a few days. The administration of OFLX was continued up to 14 days. The daily doses of OFLX during the co-medication with CP succinate were 600 mg in one case and 900 mg in the other case. In both cases no recurrence was observed clinically and bacteriologically for six months after their discharge. No adverse reaction was observed throughout the therapy.
Kurimura
O
O
Institute of Clinical Research, Kure National Hospital.
Ichimura
H
H
Koda
T
T
Honda
S
S
Tamura
I
I
Doi
H
H
D000293:Adolescent; D000328:Adult; D002701:Chloramphenicol / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D006801:Humans; D008297:Male; D015242:Ofloxacin / Q000008:administration & dosage / Q000627:therapeutic use*; D014435:Typhoid Fever / Q000188:drug therapy*
D002701:Chloramphenicol; D015242:Ofloxacin